Bharat Immunologicals Price to Earning vs. Price to Book

BIBCL -- India Stock  

INR 19.75  1.60  7.49%

The Drivers Module shows relationships between Bharat Immunologicals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bharat Immunologicals Biologicals Corp Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities

Bharat Immunologicals Price to Book vs. Price to Earning Fundamental Analysis

Bharat Immunologicals Biologicals Corp Ltd is number one stock in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about  0.01  of Price to Book per Price to Earning. The ratio of Price to Earning to Price to Book for Bharat Immunologicals Biologicals Corp Ltd is roughly  130.79 
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Bharat Immunologicals 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
=
262.88 times
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
Bharat Immunologicals 
P/B 
 = 
MV Per Share 
BV Per Share 
=
2.01 times
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Bharat Immunologicals Price to Book Comparison

Bharat Immunologicals is currently under evaluation in price to book category among related companies.
Bharat Immunologicals is currently under evaluation in price to earning category among related companies.